萬科海外(01036.HK)年度純利升39.28%至1.86億港元
格隆匯 3 月 26日丨萬科海外(01036.HK)公佈,截至2020年12月31日止12個月,公司實現收入4.75億港元,同比增長88.69%;毛利3.05億元,同比增長77.16%;公司股東應占期內盈利1.86億港元,同比增長39.28%,每股盈利0.48港仙,擬派末期息每股0.09港元。
扣除投資物業公允價值變動及應占聯營公司業績後,集團於年內的相關盈利約為2.34億港元,增幅約為102%。有關增幅主要由於(i)集團於2019年6月收購的投資工具利息收入增加;(ii)集團於2019年6月收購的投資物業所產生的純利增加;及(iii)集團於2019年6月開始提供資產管理服務產生純利增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.